Cargando…
Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920124/ https://www.ncbi.nlm.nih.gov/pubmed/33653212 http://dx.doi.org/10.1080/21645515.2021.1883379 |
_version_ | 1784669059603759104 |
---|---|
author | Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel |
author_facet | Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel |
author_sort | Heppe Montero, Marco |
collection | PubMed |
description | Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of severe bronchiolitis in Spain through population-based estimates of hospitalizations due to bronchiolitis in children up to 24 months old during a 6-year period (2012–2017). A total of 100,115 cases of bronchiolitis required hospitalization in Spain from 2012 to 2017. Most cases of bronchiolitis that required hospitalization were in infants under 3 months of age. The hospitalization rate for bronchiolitis for children under 1 year of age was 3,838.27 per 100,000 healthy children. During the 6-year study period, a total of 82 deaths due to bronchiolitis were reported among hospitalized infants. Among these deaths, more than 50% were in patients younger than 3 months of age. The annual average cost to the National Health Care System was €58 M, with a mean hospitalization cost of €3,512 per case. |
format | Online Article Text |
id | pubmed-8920124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89201242022-03-15 Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel Hum Vaccin Immunother Novel Vaccines – Research Paper Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children. The objective of this retrospective epidemiological study was to show the burden of severe bronchiolitis in Spain through population-based estimates of hospitalizations due to bronchiolitis in children up to 24 months old during a 6-year period (2012–2017). A total of 100,115 cases of bronchiolitis required hospitalization in Spain from 2012 to 2017. Most cases of bronchiolitis that required hospitalization were in infants under 3 months of age. The hospitalization rate for bronchiolitis for children under 1 year of age was 3,838.27 per 100,000 healthy children. During the 6-year study period, a total of 82 deaths due to bronchiolitis were reported among hospitalized infants. Among these deaths, more than 50% were in patients younger than 3 months of age. The annual average cost to the National Health Care System was €58 M, with a mean hospitalization cost of €3,512 per case. Taylor & Francis 2021-03-02 /pmc/articles/PMC8920124/ /pubmed/33653212 http://dx.doi.org/10.1080/21645515.2021.1883379 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Novel Vaccines – Research Paper Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title | Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title_full | Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title_fullStr | Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title_full_unstemmed | Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title_short | Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017 |
title_sort | burden of severe bronchiolitis in children up to 2 years of age in spain from 2012 to 2017 |
topic | Novel Vaccines – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920124/ https://www.ncbi.nlm.nih.gov/pubmed/33653212 http://dx.doi.org/10.1080/21645515.2021.1883379 |
work_keys_str_mv | AT heppemonteromarco burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017 AT gilprietoruth burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017 AT walterstefan burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017 AT aleixandreblanquerfernando burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017 AT gildemiguelangel burdenofseverebronchiolitisinchildrenupto2yearsofageinspainfrom2012to2017 |